Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Karen Anjema"'
Autor:
Annemiek M. J. van Wegberg, Nenad Blau, Francjan J. van Spronsen, Charlotte M A Lubout, Danique van Vliet, Esther van Dam, Karen Anjema, Roeland A F Evers
Publikováno v:
Journal of Inherited Metabolic Disease, 43, 2, pp. 244-250
Journal of Inherited Metabolic Disease, 43(2), 244-250. SPRINGER
Journal of Inherited Metabolic Disease, 43, 244-250
Journal of Inherited Metabolic Disease, 43(2), 244-250. SPRINGER
Journal of Inherited Metabolic Disease, 43, 244-250
Contains fulltext : 220018.pdf (Publisher’s version ) (Closed access) OBJECTIVE: This study aimed to investigate and improve the usefulness of the 48-hour BH(4) loading test and to assess genotype for BH(4) responsiveness prediction, using the new
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7acef1120fcea00165cc9d97109c7f91
https://hdl.handle.net/2066/220018
https://hdl.handle.net/2066/220018
Autor:
Roeland A F, Evers, Annemiek M J, van Wegberg, Karen, Anjema, Charlotte M A, Lubout, Esther, van Dam, Danique, van Vliet, Nenad, Blau, Francjan J, van Spronsen
Publikováno v:
Journal of inherited metabolic diseaseREFERENCES. 43(2)
This study aimed to investigate and improve the usefulness of the 48-hour BHApplying the definition of the European guidelines (≥100% increase in natural protein tolerance) and an amended definition (≥100% increase in natural protein tolerance or
Autor:
Rianne Jahja, Karen Anjema, Francjan J. van Spronsen, Ido P. Kema, M. Rebecca Heiner-Fokkema, Geertje B. Liemburg, Terry G J Derks, Danique van Vliet, Martijn de Groot, Eddy A. van der Zee
Publikováno v:
Molecular Genetics and Metabolism, 114(1), 29-33. ACADEMIC PRESS INC ELSEVIER SCIENCE
In phenylketonuria (PKU), cerebral neurotransmitter deficiencies have been suggested to contribute to brain dysfunction. Present treatment aims to reduce blood phenylalanine concentrations by a phenylalanine-restricted diet, while in some patients bl
Autor:
Carolien C. A. Boelen, Annet M. Bosch, Francjan J. van Spronsen, Margreet van Rijn, Floris C. Hofstede, Karen Anjema, M. Estela Rubio-Gozalbo, Maaike de Vries
Publikováno v:
Orphanet Journal of Rare Diseases, 11, 1, pp. 10
Orphanet journal of rare diseases, 11:10. BMC
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, 11:10. BioMed Central Ltd
Orphanet Journal of Rare Diseases, 11, 10
Orphanet journal of rare diseases, 11(1). BioMed Central
Orphanet Journal of Rare Diseases, 11. BioMed Central
Orphanet Journal of Rare Diseases, 11
Orphanet journal of rare diseases, 11:10. BMC
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, 11:10. BioMed Central Ltd
Orphanet Journal of Rare Diseases, 11, 10
Orphanet journal of rare diseases, 11(1). BioMed Central
Orphanet Journal of Rare Diseases, 11. BioMed Central
Orphanet Journal of Rare Diseases, 11
Contains fulltext : 171759.pdf (Publisher’s version ) (Open Access) BACKGROUND: It is unknown whether the neonatal tetrahydrobiopterin (BH4) loading test is adequate to diagnose long-term BH4 responsiveness in PKU. Therefore we compared the predict
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a93d36297ea2c5830a17991a8d11f5f8
https://doi.org/10.1186/s13023-016-0394-2
https://doi.org/10.1186/s13023-016-0394-2
Autor:
Johannes G. M. Burgerhof, M. Rebecca Heiner-Fokkema, Francjan J. van Spronsen, Margreet van Rijn, Karen Anjema, Paul H. Verkerk
Publikováno v:
Molecular Genetics and Metabolism, 104(3), 231-234. ACADEMIC PRESS INC ELSEVIER SCIENCE
UNLABELLED: In phenylketonuria, knowledge about the relation between behavior and plasma phenylalanine is scarce. The aim of this study was to determine whether high phenylalanine is associated with disturbed behavior noticed by the patient and or cl
Autor:
M. van Rijn, M. E. Rubio-Gozalbo, R.G. Janssen-Regelink, H.E.E. Zweers-van Essen, M.R. Heiner-Fokkema, N.A. van der Herberg-van de Wetering, C. C. Boelen, M.C. de Vries, C. E. M. Hollak, G. Venema, Annet M. Bosch, E.M.C. van der Ploeg, F. J. van Spronsen, N.M. Ter Horst, C. Jonkers, F.C. Hofstede, E. C. Carbasius Weber, Mirian C. H. Janssen, Karen Anjema
Publikováno v:
Molecular genetics and metabolism, 104(Suppl), S60-S63. Academic Press Inc.
Molecular Genetics and Metabolism, 104 Suppl, pp. S60-3
Molecular Genetics and Metabolism, 104, S60-S63. ACADEMIC PRESS INC ELSEVIER SCIENCE
Molecular Genetics and Metabolism, 104 Suppl, S60-3
Molecular Genetics and Metabolism, 104, S60-S63. Academic Press Inc.
Molecular Genetics and Metabolism, 104 Suppl, pp. S60-3
Molecular Genetics and Metabolism, 104, S60-S63. ACADEMIC PRESS INC ELSEVIER SCIENCE
Molecular Genetics and Metabolism, 104 Suppl, S60-3
Molecular Genetics and Metabolism, 104, S60-S63. Academic Press Inc.
Item does not contain fulltext BACKGROUND: The 24- and 48-hour tetrahydrobiopterin (BH4) loading test (BLT) performed at a minimum baseline phenylalanine concentration of 400 mumol/l is commonly used to test phenylketonuria patients for BH4 responsiv
Autor:
Karen Anjema, Johannes G. M. Burgerhof, Floris C. Hofstede, Annet M. Bosch, Mirian C. H. Janssen, Nenad Blau, Francjan J. van Spronsen, Margreet van Rijn, Maaike de Vries, Carolien C. A. Boelen, M. Rebecca Heiner-Fokkema, Carla E. M. Hollak, Estela Rubio-Gozalbo
Publikováno v:
Orphanet journal of rare diseases, 8(1). BioMed Central
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, 8(1). BioMed Central Ltd
Orphanet journal of rare diseases, 8:103. BMC
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, 8(1). BioMed Central Ltd
Orphanet journal of rare diseases, 8:103. BMC
Background: How to efficiently diagnose tetrahydrobiopterin (BH4) responsiveness in patients with phenylketonuria remains unclear. This study investigated the positive predictive value (PPV) of the 48-hour BH4 loading test and the additional value of
Autor:
Karen Anjema, Stefanie Keil, Vincenzo Leuzzi, Alberto Burlina, Annet M. Bosch, N. Lambruschini, Lena Damaj, Thierry Billette de Villemeur, Nenad Blau, María L. Couce, François Feillet, Concetta Meli, Marcello Giovannini, Amaya Belanger-Quintana, Ania C. Muntau, Enrica Riva, Roberto Cerone, Francjan J. van Spronsen, Amelie S. Lotz-Havla, Ilse Kern
Publikováno v:
Pediatrics
Pediatrics, American Academy of Pediatrics, 2013, 131 (6), pp.e1881-e1888. ⟨10.1542/peds.2012-3291⟩
Pediatrics, 131(6), E1881-E1888. AMER ACAD PEDIATRICS
Pediatrics, 131(6), e1881-e1888. American Academy of Pediatrics
Pediatrics, Vol. 131, No 6 (2013) pp. e1881-8
Pediatrics, 2013, 131 (6), pp.e1881-e1888. ⟨10.1542/peds.2012-3291⟩
Pediatrics, American Academy of Pediatrics, 2013, 131 (6), pp.e1881-e1888. ⟨10.1542/peds.2012-3291⟩
Pediatrics, 131(6), E1881-E1888. AMER ACAD PEDIATRICS
Pediatrics, 131(6), e1881-e1888. American Academy of Pediatrics
Pediatrics, Vol. 131, No 6 (2013) pp. e1881-8
Pediatrics, 2013, 131 (6), pp.e1881-e1888. ⟨10.1542/peds.2012-3291⟩
OBJECTIVE: Sapropterin dihydrochloride, the synthetic form of 6R-tetrahydrobiopterin (BH4), is an approved drug for the treatment of patients with BH4-responsive phenylketonuria (PKU). The purpose of this study was to assess genotypes and data on the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4939254f6498f70ddb36b94beb60a0cd
https://hal.univ-lorraine.fr/hal-01704390
https://hal.univ-lorraine.fr/hal-01704390